Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
b decrease » _ decrease (Expand Search), b1 decreased (Expand Search), ob decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
b decrease » _ decrease (Expand Search), b1 decreased (Expand Search), ob decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
3001
-
3002
Responses to speech onset and target nouns in relation to cognitive decline and context.
Published 2024Subjects: -
3003
-
3004
Speech material modulation spectrum and behavioral speech recognition task results.
Published 2024Subjects: -
3005
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
Published 2025“…With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…”
-
3006
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
Published 2025“…With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…”
-
3007
Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms
Published 2025“…With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…”
-
3008
Projected ASIR and ASMR of LC in China over the next 15 years based on the Bayesian APC model.
Published 2025Subjects: -
3009
-
3010
-
3011
-
3012
-
3013
-
3014
-
3015
-
3016
Estimated marginal mean (± SE) age group differences in the relative frequency of releases per minute, performed by professional soccer players on a match day for each position.
Published 2025Subjects: “…tailed statistical significance…”
-
3017
-
3018
Descriptive statistics of alcohol consumption in G7 countries (in litres/capita).
Published 2024Subjects: -
3019
-
3020